Design Therapeutics, Inc. Operating Lease Cost
Design Therapeutics, Inc. (DSGN) reported Operating Lease Cost of $400.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-08-03
- Design Therapeutics, Inc. operating lease, cost for the quarter ending 2026-06-30 was $200.00K, a 0.00% change year-over-year.
- Design Therapeutics, Inc. operating lease, cost for the quarter ending 2026-03-31 was $200.00K, a 0.00% change year-over-year.
- Design Therapeutics, Inc. operating lease, cost for the quarter ending 2025-12-31 was $200.00K, a 0.00% change year-over-year.
- Design Therapeutics, Inc. operating lease, cost for the quarter ending 2025-09-30 was $200.00K, a 0.00% change year-over-year.
- Design Therapeutics, Inc. operating lease, cost for fiscal 2025 was $900.00K, a 0.00% change from fiscal 2024.
- Design Therapeutics, Inc. operating lease, cost for fiscal 2024 was $900.00K, a 0.00% change from fiscal 2023.
- Design Therapeutics, Inc. operating lease, cost for fiscal 2023 was $900.00K, a 0.00% change from fiscal 2022.
- Design Therapeutics, Inc. operating lease, cost for fiscal 2022 was $900.00K, a 50.00% increase from fiscal 2021.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 3 month as first filed | Operating Lease, Cost 6 month | Operating Lease, Cost 6 month as first filed | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $400.00K 10-Q · filed 2026-08-03 | $600.00K derived: sum of 3 quarters · filed 2026-08-03 | $800.00K derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2026-03-31 | $200.00K 10-Q · filed 2026-08-03 | $400.00K derived: sum of 2 quarters · filed 2026-08-03 | $600.00K derived: sum of 3 quarters · filed 2026-08-03 | $800.00K derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2025-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $400.00K derived: sum of 2 quarters · filed 2026-03-09 | $600.00K derived: sum of 3 quarters · filed 2026-03-09 | $900.00K 10-K · filed 2026-03-09 | ||
| 2025-09-30 | $200.00K 10-Q · filed 2025-11-05 | $400.00K derived: sum of 2 quarters · filed 2025-11-05 | $700.00K 10-Q · filed 2025-11-05 | $800.00K derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2025-06-30 | $200.00K 10-Q · filed 2025-08-07 | $500.00K 10-Q · filed 2026-08-03 | $600.00K derived: sum of 3 quarters · filed 2026-08-03 | $800.00K derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2025-03-31 | $200.00K 10-Q · filed 2026-08-03 | $400.00K derived: sum of 2 quarters · filed 2026-08-03 | $600.00K derived: sum of 3 quarters · filed 2026-08-03 | $800.00K derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2024-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $400.00K derived: sum of 2 quarters · filed 2026-03-09 | $600.00K derived: sum of 3 quarters · filed 2026-03-09 | $900.00K 10-K · filed 2026-03-09 | ||
| 2024-09-30 | $200.00K 10-Q · filed 2025-11-05 | $400.00K derived: sum of 2 quarters · filed 2025-11-05 | $700.00K 10-Q · filed 2025-11-05 | $800.00K derived: sum of 4 quarters · filed 2025-11-05 | ||
| 2024-06-30 | $200.00K 10-Q · filed 2025-08-07 | $500.00K 10-Q · filed 2025-08-07 | $600.00K derived: sum of 3 quarters · filed 2025-08-07 | $800.00K derived: sum of 4 quarters · filed 2025-08-07 | ||
| 2024-03-31 | $200.00K 10-Q · filed 2025-05-07 | $400.00K derived: sum of 2 quarters · filed 2025-05-07 | $600.00K derived: sum of 3 quarters · filed 2025-05-07 | $800.00K derived: sum of 4 quarters · filed 2025-05-07 | ||
| 2023-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $400.00K derived: sum of 2 quarters · filed 2025-03-10 | $600.00K derived: sum of 3 quarters · filed 2025-03-10 | $900.00K 10-K · filed 2025-03-10 | ||
| 2023-09-30 | $200.00K 10-Q · filed 2024-11-07 | $400.00K derived: sum of 2 quarters · filed 2024-11-07 | $700.00K 10-Q · filed 2024-11-07 | $900.00K derived: sum of 4 quarters · filed 2024-11-07 | ||
| 2023-06-30 | $200.00K 10-Q · filed 2024-08-05 | $500.00K 10-Q · filed 2024-08-05 | $700.00K derived: sum of 3 quarters · filed 2024-08-05 | $900.00K derived: sum of 4 quarters · filed 2024-08-05 | ||
| 2023-03-31 | $200.00K 10-Q · filed 2024-05-08 | $500.00K derived: sum of 2 quarters · filed 2024-05-08 | $700.00K derived: sum of 3 quarters · filed 2024-05-08 | $900.00K derived: sum of 4 quarters · filed 2024-05-08 | ||
| 2022-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $500.00K derived: sum of 2 quarters · filed 2024-03-19 | $700.00K derived: sum of 3 quarters · filed 2024-03-19 | $900.00K 10-K · filed 2024-03-19 | ||
| 2022-09-30 | $200.00K 10-Q · filed 2023-11-13 | $400.00K derived: sum of 2 quarters · filed 2023-11-13 | $600.00K 10-Q · filed 2023-11-13 | $800.00K derived: sum of 4 quarters · filed 2023-11-13 | ||
| 2022-06-30 | $200.00K 10-Q · filed 2023-08-14 | $400.00K 10-Q · filed 2023-08-14 | $600.00K derived: sum of 3 quarters · filed 2023-08-14 | $800.00K derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | $200.00K 10-Q · filed 2023-05-09 | $400.00K derived: sum of 2 quarters · filed 2023-05-09 | $600.00K derived: sum of 3 quarters · filed 2023-05-09 | $700.00K derived: sum of 4 quarters · filed 2023-05-09 | ||
| 2021-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $400.00K derived: sum of 2 quarters · filed 2023-03-14 | $500.00K derived: sum of 3 quarters · filed 2023-03-14 | $600.00K 10-K · filed 2023-03-14 | ||
| 2021-09-30 | $200.00K 10-Q · filed 2022-11-03 | $300.00K derived: sum of 2 quarters · filed 2022-11-03 | $400.00K 10-Q · filed 2022-11-03 | $400.00K derived: sum of 4 quarters · filed 2022-11-03 | ||
| 2021-06-30 | $100.00K 10-Q · filed 2022-08-08 | $136.00K 10-Q · filed 2021-08-09 | $200.00K 10-Q · filed 2022-08-08 | $212.00K 10-Q · filed 2021-08-09 | $200.00K derived: sum of 3 quarters · filed 2022-08-08 | $266.00K derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $100.00K 10-Q · filed 2022-05-09 | $76.00K 10-Q · filed 2021-05-10 | $100.00K derived: sum of 2 quarters · filed 2022-05-09 | $166.00K derived: sum of 3 quarters · filed 2022-05-09 | $188.00K derived: sum of 4 quarters · filed 2022-05-09 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $66.00K derived: sum of 2 quarters · filed 2022-03-10 | $88.00K derived: sum of 3 quarters · filed 2022-03-10 | $100.00K 10-K · filed 2022-03-10 | ||
| 2020-09-30 | $66.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $88.00K derived: sum of 2 quarters · filed 2021-11-09 | $100.00K 10-Q · filed 2021-11-09 | |||
| 2020-06-30 | $22.00K 10-Q · filed 2021-08-09 | $34.00K 10-Q · filed 2021-08-09 | ||||
| 2020-03-31 | $12.00K 10-Q · filed 2021-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |